NO20043018L - Streptococcus pneumoniae vaksine - Google Patents

Streptococcus pneumoniae vaksine

Info

Publication number
NO20043018L
NO20043018L NO20043018A NO20043018A NO20043018L NO 20043018 L NO20043018 L NO 20043018L NO 20043018 A NO20043018 A NO 20043018A NO 20043018 A NO20043018 A NO 20043018A NO 20043018 L NO20043018 L NO 20043018L
Authority
NO
Norway
Prior art keywords
streptococcus pneumoniae
pneumoniae vaccine
vaccine
streptococcus
pneumoniae
Prior art date
Application number
NO20043018A
Other languages
English (en)
Norwegian (no)
Inventor
Jan Poolman
Craig Anthony Josep Laferriere
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20043018L publication Critical patent/NO20043018L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20043018A 2001-12-18 2004-07-15 Streptococcus pneumoniae vaksine NO20043018L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130215.7A GB0130215D0 (en) 2001-12-18 2001-12-18 Vaccine
PCT/EP2002/014476 WO2003051392A2 (en) 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine

Publications (1)

Publication Number Publication Date
NO20043018L true NO20043018L (no) 2004-07-15

Family

ID=9927830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043018A NO20043018L (no) 2001-12-18 2004-07-15 Streptococcus pneumoniae vaksine

Country Status (19)

Country Link
US (1) US20050214329A1 (zh)
EP (1) EP1463519A2 (zh)
JP (1) JP2005516932A (zh)
KR (1) KR20040074091A (zh)
CN (1) CN1635904A (zh)
AU (1) AU2002361007A1 (zh)
BR (1) BR0215089A (zh)
CA (1) CA2470645A1 (zh)
CO (1) CO5590937A2 (zh)
GB (1) GB0130215D0 (zh)
HU (1) HUP0402471A3 (zh)
IL (1) IL162383A0 (zh)
IS (1) IS7297A (zh)
MX (1) MXPA04006073A (zh)
NO (1) NO20043018L (zh)
PL (1) PL370804A1 (zh)
RU (1) RU2004117775A (zh)
WO (1) WO2003051392A2 (zh)
ZA (1) ZA200404803B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763244B1 (fr) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2011253684B8 (en) * 2005-04-08 2013-07-11 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
CN101180079B (zh) 2005-04-08 2012-07-18 惠氏公司 多价肺炎球菌多糖-蛋白质缀合物组合物
NZ569168A (en) * 2005-12-22 2012-02-24 Glaxosmithkline Biolog Sa Streptococcus pneumoniae polysaccharide conjugate vaccine comprising 19F-DT conjugate
AU2012216698B2 (en) * 2005-12-22 2014-03-06 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate vaccine
US20070253985A1 (en) * 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
WO2008022299A1 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Diagnosing pneumococcal pneumonia
CN1971275B (zh) * 2006-12-06 2012-07-04 云南沃森生物技术股份有限公司 肺炎链球菌6b型、18c型、19f型、23f型多糖结合物中游离多糖含量的测定方法
UY31064A1 (es) * 2007-05-02 2009-01-05 Glaxosmithkline Biolog Sa Vacuna
KR101579947B1 (ko) * 2007-06-26 2015-12-28 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신
WO2009012588A1 (en) * 2007-07-23 2009-01-29 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
CN103501808A (zh) 2010-12-03 2014-01-08 赛诺菲巴斯德有限公司 用于针对肺炎链球菌免疫的组合物
SG11201404447WA (en) * 2012-01-30 2014-08-28 Serum Inst India Ltd Immunogenic composition
CN104853768B (zh) * 2012-10-17 2019-04-19 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN106109486A (zh) * 2015-07-06 2016-11-16 北京科兴中维生物技术有限公司 一种组合物及其制备方法与应用
US11246918B2 (en) 2017-02-03 2022-02-15 Eva Barbara Schadeck Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR102634811B1 (ko) * 2017-06-10 2024-02-06 인벤트프라이즈 인크. 면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
MX2020008198A (es) 2018-02-05 2020-09-22 Sanofi Pasteur Inc Composicion del conjugado proteina-polisacarido multivalente neumococica.
BR112020021296A2 (pt) * 2018-04-18 2021-01-26 Sk Bioscience Co., Ltd. polissacarídeo capsular de streptococcus pneumoniae e conjugado imunogênico do mesmo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
DE60038166T2 (de) * 1999-03-19 2009-03-12 Glaxosmithkline Biologicals S.A., Rixensart Impfstoff gegen bakterielle antigene

Also Published As

Publication number Publication date
IL162383A0 (en) 2005-11-20
IS7297A (is) 2004-06-03
WO2003051392A3 (en) 2003-11-13
PL370804A1 (en) 2005-05-30
KR20040074091A (ko) 2004-08-21
JP2005516932A (ja) 2005-06-09
BR0215089A (pt) 2004-11-16
RU2004117775A (ru) 2005-04-20
AU2002361007A1 (en) 2003-06-30
GB0130215D0 (en) 2002-02-06
US20050214329A1 (en) 2005-09-29
CA2470645A1 (en) 2003-06-26
WO2003051392A2 (en) 2003-06-26
MXPA04006073A (es) 2005-03-31
CN1635904A (zh) 2005-07-06
HUP0402471A3 (en) 2005-04-28
HUP0402471A2 (hu) 2005-03-29
ZA200404803B (en) 2005-08-29
EP1463519A2 (en) 2004-10-06
CO5590937A2 (es) 2005-12-30

Similar Documents

Publication Publication Date Title
NO20043018L (no) Streptococcus pneumoniae vaksine
ATE346608T1 (de) Impstoff gegen streptococcus pneumoniae
NO20026121D0 (no) Streptokokkantigener
GB0107658D0 (en) Streptococcus pneumoniae
NO20031483D0 (no) Vaksine
DK1390066T3 (da) Vaccinesammensætning
AU2002351623A8 (en) Streptococcus antigens
NO20024172D0 (no) Vaksine
DE60139008D1 (de) CVD-Verfahren
DE60134243D1 (de) Biegevorrichtung
DK1427444T3 (da) West-nil-vaccine
DK1303521T3 (da) Tetrahydro-heterocycloazepinyl-pyrimidinderivater
DE60208379D1 (de) Haltevorrichtung
NO20033882L (no) Vaksine
DK1265633T3 (da) Vaccineadjuvans
DE10293048T1 (de) Neuer Impfstoff
DE60221403D1 (de) Doppelstrom - verdichter
EE200300480A (et) Pregabaliini-laktoosi konjugaadid
DE60220505D1 (de) Haarwaschmittel
ATA17102002A (de) Distanzhalter
DE50108952D1 (de) Halteelement
ES1049528Y (es) Almohada hidroneumatica
ITPO20010001U1 (it) Guanciale orozio
UA6118S (uk) Подушка
ITBO20010095V0 (it) Dispositivo distanziatore

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application